{"id":"W4387733267","doi":"10.14309/01.ajg.0000954128.19144.0e","title":"S1122 Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Non-Complicated Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2023,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"","keywords":"Medicine; Vedolizumab; Internal medicine; Adverse effect; Discontinuation; Ustekinumab; Hazard ratio; Observational study; Crohn's disease; Disease; Confidence interval; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006599127,0.0003598793,0.001123158,0.0004342491,0.0002667305,0.00117702,0.0004130878,0.0004906476,0.003920056],"category_scores_gemma":[0.01080632,0.0002030226,0.001950949,0.00118004,0.0003763791,0.0007451618,0.0007068501,0.0005847798,0.0004940585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005751923,"about_ca_system_score_gemma":0.0009273015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009434386,"about_ca_topic_score_gemma":0.00192979,"domain_scores_codex":[0.9962327,0.00185636,0.000612251,0.0004182831,0.0007384223,0.0001420258],"domain_scores_gemma":[0.9854293,0.006175598,0.00558474,0.00110978,0.001056191,0.0006443113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08188966,0.001601788,0.8118242,0.002931074,0.009279425,0.000204207,0.0003556987,0.001896109,0.001882483,0.0005666718,0.009424111,0.07814458],"study_design_scores_gemma":[0.01339312,0.01241304,0.9536818,0.0007120339,0.004062131,0.0005662118,0.0001955167,0.002085277,0.001201072,0.0003947871,0.0112266,0.00006843101],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9723135,0.005547899,0.0004205203,0.0004462999,0.00006350575,0.0004008301,0.01763241,0.00002764138,0.003147469],"genre_scores_gemma":[0.9707698,0.001363197,0.001206303,0.0005259899,0.0002632526,0.0006656072,0.02453277,0.0000187621,0.0006543138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006599127,"threshold_uncertainty_score":0.03489995,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00907441852498853,"score_gpt":0.2755946975270267,"score_spread":0.2665202790020382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}